Key facts
- This page summarizes Brigitte King's Form 4 filing for FLOWERS FOODS INC (FLO).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 01 Jun 2026, 17:57.
Brigitte King - 29 May 2026 Form 4 Insider Report for FLOWERS FOODS INC (FLO)
- Reporting relationship
- Director
- Issuer ticker
- FLO
- Reported as of
- 29 May 2026
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 01 Jun 2026, 17:57:58 UTC
- Prior SEC filing
- 27 May 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Stephanie B. Tillman, Agent
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Brigitte King filed Form 4 for FLOWERS FOODS INC (FLO) on 01 Jun 2026.
Change
- Previous filing in this sequence was filed on 27 May 2025.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001996338
Primary reporting owner
KING BRIGITTE
- Relationship
- Director
- Address
- 1919 FLOWERS CIRCLE, THOMASVILLE
- Signature
- /s/ Stephanie B. Tillman, Agent
- Signature date
- 01 Jun 2026
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
FLO
transaction
Derivative
Deferred Stock
Award
- Transaction value
- Shares
- +22,260
- Change %
- Price
- $0.000000*
- Shares after
- 22,260
- Date
- 29 May 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 22,260
- Exercise price
- $0.000000
- Footnotes
- F1, F2, F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
Granted under the Flowers Foods, Inc. 2026 Equity and Incentive Compensation Plan.
Footnote F2
In accordance with the terms of the Deferred Shares Agreement for Directors, the deferred shares awarded do not have a conversion or exercise price.
Footnote F3
No expiration date.